Here's the summary of the investor presentation:
**1. Financial Highlights:**
Consolidated revenue grew 1.7% YoY to INR 3,404.6 Cr for the quarter. Operating Profit rose 2% to INR 667.8 Cr, with margins maintained at 19.6%. Net Profit increased 2.8% to INR 513.9 Cr, expanding PAT margin by 20 bps.
**2. Strategic Initiatives & Growth Drivers:**
95% of the portfolio gained market share, with rural growth outpacing urban by 400 bps. Key healthcare power brands like Honey, Honitus, and Chyawanprash recorded double-digit growth. Strategic price increases, cost savings, and a focus on premiumization helped navigate inflation.
**3. Business Developments:**
International business saw robust 13.7% constant currency growth. Domestically, Home & Personal Care (HPC) grew 5%, and Healthcare (excluding Glucose) grew 2.7%. Strong performance in Oral Care, Home Care (Odonil, Odomos), Skin Care (Gulabari), and Health Supplements (Chyawanprash, Honey) drove market share gains.
**4. Market Position & Competitive Advantage:**
Widespread market share gains across most categories (e.g., Oral Care, Air Fresheners, Bleach, Hair Oils, Digestives, Nectars) underscore strong brand power and competitive edge. The ability to maintain operating margins despite high inflation reflects brand resilience and efficient cost management.
**5. Investor Implications:**
Consistent market share gains and strategic initiatives point to positive growth potential, even amidst challenging operating environments. The company's ability to grow profits ahead of topline while maintaining margins is a positive signal for future profitability.